(CLX)

Reporting relationship: Director
Issuer ticker: CLX
Reported as of: 31 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jan 2026, 16:44:44 UTC
Prior SEC filing: 02 Oct 2025
Source filing: View source filing
Reporting owner signature: By Jinho Joo, Attorney-in-Fact

Key filing fact

Spencer C. Fleischer filed Form 4 for CLOROX CO /DE/ (CLX) on 05 Jan 2026.

Key facts

This page summarizes Spencer C. Fleischer's Form 4 filing for CLOROX CO /DE/ (CLX).
3 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 05 Jan 2026, 16:44.

Change

Previous filing in this sequence was filed on 02 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001235824 Primary reporting owner

Fleischer Spencer C

Relationship: Director
Address: 1221 BROADWAY, OAKLAND
Signature: By Jinho Joo, Attorney-in-Fact
Signature date: 05 Jan 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLX transaction Derivative

Deferred Stock Units

Award

Transaction value: $0
Shares: +219
Change %: +1.2%
Price: $0.000000
Shares after: 19,019
Date: 06 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 219
Exercise price
Footnotes: F1, F2, F3

CLX transaction Derivative

Deferred Stock Units

Award

Transaction value: $0
Shares: +1,219
Change %: +6.4%
Price: $0.000000
Shares after: 20,238
Date: 31 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,219
Exercise price
Footnotes: F1, F3, F4

CLX transaction Derivative

Deferred Stock Units

Award

Transaction value: $0
Shares: +145
Change %: +0.72%
Price: $0.000000
Shares after: 20,383
Date: 31 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 145
Exercise price
Footnotes: F1, F3, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

1-for-1

Footnote F2

Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

Footnote F3

The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

Footnote F4

Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.

Footnote F5

Receipt of Deferred Stock Units in lieu of portion of quarterly director's fees.